Methadone Market Analysis

Market Insights

Pain is one of the most widely recognized ailments and about 85% of individuals are accounted to suffer from pain worldwide at some point in their life. Methadone is a synthetic narcotic analgesic, which is part of a category known as opioids. This opioid drug has pharmacologic actions qualitatively similar to that of morphine. It is mainly used as a pain reliever and as a part of maintenance therapy and drug addiction detoxification.

The growing prevalence of pain associated with post-surgical and therapeutic treatment of cancer and other chronic diseases is expected to be the prime factor driving the need for methadone. Moreover, rising incidents of opioid abuse and an increasing number of heroin and other drug-adapted people and their treatment that involves short-term administration of methadone hydrochloride further add to the substantial market growth. However, the high risks associated with the usage of methadone among patients suffering from breathing problems and severe asthma are expected to hamper the market expansion.

The outbreak of the COVID-19 virus has been challenging to the healthcare sector. Due to stringent lockdown measures and restricted movement on the streets, there has been a surge in drug overdosage in most parts of the world. Drug overdose deaths have substantially increased.

The US states are reporting a surge in drug fatalities in 2020 as the coronavirus pandemic has created new obstacles resulting in high opioid usage, risk, and abuse of relapse for those in recovery.

The people who are battling addiction, social distancing, and quarantine have led to disruption in treatment and recovery services as well as poor access to mental health services and peer support, thus affecting the market growth.

Key Players

Key players operating in the global methadone market are-

• Eli Lilly and Company (The U.S),
• Sanofi (France),
• Roxane Laboratories (The U.S),
• Mallinckrodt (UK),
• Siegfried AG (Switzerland),
• Johnson Matthey (UK),
• Tianjin Central Pharma (China),
• Macfarlan Smith (UK), and
• Vistapharm (The U.S).

Segment Analysis

Route of Administration Trends

By route of administration, the global methadone market has been bifurcated into oral and injectable.

• The oral segment is further segmented into tablets and oral solutions.
• Under these, the oral segment witnessed the largest market share in 2022 and is likely to register a moderate CAGR in the coming years.
• This is mainly attributed to the high-performance efficiency and easy availability of the drug in various forms and dosages.

Regional Insights

By region, the North American market garnered the largest market share in 2022 and is likely to register a healthy CAGR during the review period.

• This is mainly attributed to the higher predominance of the agony and rising incidents of drug addiction, further boosting regional growth.
• Moreover, high distress with rising occurrences of people utilization of methadone for chronic post-surgery pains.

Want to get a free sample? Register Here

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Target Audience

Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

• Distributors
• Suppliers
• Manufacturers
• Logistics organizations
• Government bodie

This report studies the market covering 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The global methadone market is segmented into the following categories.

By Route Of Administration

• Oral
  • Tablets
  • Oral solutions
• Injectable

By Therapeutic Area 

• Pain treatment
• Detoxification
• Maintenance therapy

By Distribution Channel 

• Hospital Pharmacies
• Retail Pharmacies
• Rehab centers
• Drug Stores

By Region

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.